USSTOCK.TODAY
Regular Market
Log in Sign up

Centene CEO: Medicaid patients left behind in medical innovation

Fortune ·

CNC Centene Corp
$67.02 +2.54%
View chart & analysis →
  1. 1Centene CEO Sarah London said Medicaid patients are the last to benefit from medical innovation.
  2. 2Centene, a company with a $33 billion enterprise value, operates Medicaid plans in 29 states.
  3. 3Centene's 26 million members consist of the poorest and sickest members of their communities.

So what's the key point?

The head of Centene said that poor and sick patients are the last to receive help from new medical technology. This issue is important because the company cares for 26 million patients.

Source Fortune · View original ↗

Related 3-line summaries

Salesforce upgraded, Adobe downgraded The Fly · 15h agoMizuho Downgrades Norwegian Cruise (NCLH) to Neutral, Cuts Price Target to $17 MarketWatch +1 · Aug 18Moonshot eyes additional NVIDIA Blackwell chips for Kimi K4 Stocktwits +8 · Jul 28
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news